-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| S642958 | 68684-40-2 | (2S)-2-氨基-4-((((2S,3S,4R,5R)-5-(6-氨基-9H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基)甲基)(甲基-d3)磺酰基)丁酸内盐, ≥98%, 98 atom % D (2S)-2-Amino-4-((((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(methyl-d3)sulfonio)butanoate, ≥98%, 98 atom % D |
C15H22N6O5S | |
| F976861 | 273399-94-3 | (2s)-2-苯磺酰胺-3-([[(9h-芴-9-基)甲氧基]羰基]氨基)丙酸, 97% Fmoc-(S)3-amino-2-(phenylsulfonylamino)propionic acid, 97% |
||
| S910922 | 1391194-64-1 | (2S)-Octyl-α-hydroxyglutarate ((2S)-Octyl-2-HG), 98% (2S)-Octyl-α-hydroxyglutarate ((2S)-Octyl-2-HG), 98% |
C13H24O5 | |
| S639211 | 1883545-51-4 | (2S,2'S)-N,N'-((1S,1'S,2R,2'R)-(己-2,4-二炔-1,6-二基双(氧基))双(2,3-二氢-1H-茚-2,1-二基))双(1-((S)-2-环己基-2-((S)-2-(甲基氨基)丙酰胺基)乙酰基)吡咯烷-2-甲酰胺)二盐酸盐, 99% (2S,2'S)-N,N'-((1S,1'S,2R,2'R)-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1H-indene-2,1-diyl))bis(1-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) dihydrochloride, 99% |
C58H80Cl2N8O8 | |
| S641146 | 2828433-21-0 | (2S,3R)-2-((S)-2-((S)-1-((S)-2-((S)-2-((S)-2-((S)-2-氨基-4-甲基戊酰胺基)-3-甲基丁酰胺基)-3-甲基丁酰胺基)-3-(4-羟基苯基)丙酰基)吡咯烷-2-甲酰胺基)-3-(1H-吲哚-3-基)丙酰胺基)-3-羟基丁酸三氟乙酸盐, 97% Spinorphin TFA, 97% |
C47H65F3N8O12 | |
| S681410 | 1381926-28-8 | (2S,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)-3-methyltetrahydrofuran-2-ol, 95% (2S,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)-3-methyltetrahydrofuran-2-ol, 95% |
C33H34N4O5 | |
| S681613 | 1770840-46-4 | (2S,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-ol, 95% (2S,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-ol, 95% |
C32H32N4O5 | |
| S681645 | 2511176-38-6 | (2S,3R,4S,5R)-2-(4-(benzylamino)pyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% (2S,3R,4S,5R)-2-(4-(benzylamino)pyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% |
C18H20N4O4 | |
| S681500 | 2170185-99-4 | (2S,3R,4S,5R)-2-(4-amino-5-iodopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% (2S,3R,4S,5R)-2-(4-amino-5-iodopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95% |
C11H13IN4O4 | |
| F936970 | 7196-71-6 | (2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基 3-(4-羟基-3-甲氧基苯基)丙烯酸酯, ≥98% Ferulic acid acyl-β-D-glucoside, ≥98% |
C16H20O9 | |
| S640827 | 128427-86-1 | (2S,3R,E)-2-氨基十二-4-烯-1,3-二醇, 98% (2S,3R,E)-2-Aminododec-4-ene-1,3-diol, 98% |
C12H25NO2 | |
| S641449 | 2093449-12-6 | (2S,3S)-3-(4-氯苯基)-3-((R)-1-(4-氯苯基)-7-氟-5-((S)-1-羟基-1-(四氢-2H-吡喃-4-基)丙基)-1-甲氧基-3-氧代异吲哚啉-2-基)-2-甲基丙酸, 95% (2S,3S)-3-(4-Chlorophenyl)-3-((R)-1-(4-chlorophenyl)-7-fluoro-5-((S)-1-hydroxy-1-(tetrahydro-2H-pyran-4-yl)propyl)-1-methoxy-3-oxoisoindolin-2-yl)-2-methylpropanoic acid, 95% |
C33H34Cl2FNO6 | |
| S780011 | 28002-70-2 | (2S,3S,4R,5R,6R)-5-氨基-2-(氨基甲基)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-二氨基-2-(((2R,3R,4R,5S,6R)-3-氨基-6-(氨基甲基)-4,5-二羟基四氢-2H-吡喃-2-基)氧基)-6-羟基环己基)氧基)-4-羟基-2-(羟甲基)四氢呋喃-3-基)氧基)四氢-2H-吡喃-3,4-二醇x硫酸盐, 650 IU/mg(on dried basis) (2S,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)ox, 650 IU/mg(on dried basis) |
C23H48N6O17S | |
| A639438 | 2378056-80-3 | (2S,4R)-1-((2R)-2-(3-(4-((4-(反式-3-((4-(3-(3-氨基-6-(2-羟基苯基)哒嗪-4-基)-3,8-二氮杂双环[3.2.1]辛烷-8-基)吡啶-2-基)氧基)环丁氧基)哌啶-1-基)甲基)哌啶1-基)异恶唑-5-基)-3-甲基丁酰基)-4-羟基-N-((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)吡咯烷-2-甲酰胺, 98% A947, 98% |
C61H76N12O7S | |
| Z638864 | 2711006-67-4 | (2S,4R)-1-((2S)-2-(11-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)十一酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺 2,2,2-三氟乙酸盐, 99% ZXH-4-130 TFA, 99% |
C48H59F3N6O11S | |
| S640003 | 2675490-92-1 | (2S,4R)-1-((S)-2-(11-(4-(3-((4-((3-氯-4-氟苯基)氨基)-7-甲氧基喹唑啉-6-基)氧基)丙基)哌嗪-1-基)-11-氧代十一烷酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺, 99% (2S,4R)-1-((S)-2-(11-(4-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)-11-oxoundecanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 99% |
C55H71ClFN9O7S | |
| E639758 | 3031336-58-7 | (2S,4R)-1-((S)-2-(2-(2-(2-(4-(5-((4-((3-氯-4-氟苯基)氨基)-6-((E)-4-(哌啶-1-基)丁-2-烯酰胺基)喹唑啉-7-基)氧基)戊基)-1H-1,2,3-三唑-1-基)乙氧基)乙氧基)乙酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺, 98% EGFR PROTAC compound 17, 98% |
C58H72ClFN12O8S | |
| S681680 | 1001354-09-1 | (2S,4R)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-4-hydroxypyrrolidine-2-carboxylic acid, 95% (2S,4R)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-4-hydroxypyrrolidine-2-carboxylic acid, 95% |
C17H19N7O3 | |
| S976234 | 31137-74-3 | (2S,4R)-4-甲基谷氨酸, SYM 2081, |
||
| A642821 | 2913161-19-8 | (2S,4R)-N-((1S,4S)-6-(4-(4-溴-7-环戊基-5-氧代-5,7-二氢苯并[4,5]咪唑并[1,2-a]喹唑啉-9-基)哌啶-1-基)-4-甲基-1-(4-(4-甲基噻唑-5-基)苯基)己基-1-((S)-2-(1-氟环丙烷-1-甲酰胺基)-3,3-二甲基丁酰基)-4-羟基吡咯烷-2-甲酰胺, 95% ACBI2, 95% |
C56H68BrFN8O5S |
